Cargando…

Aerosol Inhalation of Chimpanzee Adenovirus Vectors (ChAd68) Expressing Ancestral or Omicron BA.1 Stabilized Pre–Fusion Spike Glycoproteins Protects Non–Human Primates against SARS-CoV-2 Infection

Current COVID-19 vaccines are effective countermeasures to control the SARS-CoV-2 virus pandemic by inducing systemic immune responses through intramuscular injection. However, respiratory mucosal immunization will be needed to elicit local sterilizing immunity to prevent virus replication in the na...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shen, Qin, Mian, Xu, Long, Mu, Ting, Zhao, Ping, Sun, Bing, Wu, Yue, Song, Lingli, Wu, Han, Wang, Weicheng, Liu, Xingwen, Li, Yanyan, Yang, Fengmei, Xu, Ke, He, Zhanlong, Klein, Michel, Wu, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535855/ https://www.ncbi.nlm.nih.gov/pubmed/37766104 http://dx.doi.org/10.3390/vaccines11091427

Ejemplares similares

A novel Plasmodium vivax vaccine based on recombinant chimpanzee adenovirus ChAd63 and MVA expressing TRAP
por: Bauza, Karolis, et al.
Publicado: (2012)

Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients
por: Zhao, Hua, et al.
Publicado: (2018)

Identification of Recombinant Chimpanzee Adenovirus C68 Degradation Products Detected by AEX-HPLC
por: Powers, Thomas W., et al.
Publicado: (2022)

Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
por: O’Hara, Geraldine A., et al.
Publicado: (2012)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
por: Berg, Adam, et al.
Publicado: (2021)

Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients: A multicenter prospective observational study
por: Haase, Michael, et al.
Publicado: (2022)

Characterization of Recombinant Chimpanzee Adenovirus C68 Low and High-Density Particles: Impact on Determination of Viral Particle Titer
por: Mullins, Elise K., et al.
Publicado: (2021)

Immunogenicity of ChAd63 + MVA ME-TRAP in Senegalese adults
por: Mensah, Victorine, et al.
Publicado: (2014)

Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1
por: Patel, Shreena Umit, et al.
Publicado: (2021)

Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan Africa
por: Xiang, Zhiquan, et al.
Publicado: (2006)

Intranasal delivery of a chimpanzee adenovirus vector expressing a pre-fusion spike (BV-AdCoV-1) protects golden Syrian hamsters against SARS-CoV-2 infection
por: Wang, Shen, et al.
Publicado: (2022)

Humoral immunogenicity of ChAd63_MVA ME-TRAP vaccination in African infants and children
por: Bowyer, Georgina, et al.
Publicado: (2014)

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
por: Afolabi, Muhammed O, et al.
Publicado: (2016)

Lichenoid Drug Reaction Post-COVID Vaccination with the Modified Chimpanzee Adenovirus
por: García-Mendoza, Paola, et al.
Publicado: (2022)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
por: Dicks, Matthew D. J., et al.
Publicado: (2015)

Single-Shot ChAd3-MARV Vaccine in Modified Formulation Buffer Shows 100% Protection of NHPs
por: Finch, Courtney L., et al.
Publicado: (2022)

Chad : development potential and constraints /
Publicado: (1974)

Immunological Study of Reconstructed Common Ancestral Sequence of Adenovirus Hexon Protein
por: Wang, Yingchen, et al.
Publicado: (2021)

Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
por: Warimwe, George M., et al.
Publicado: (2016)

Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle
por: Dulal, Pawan, et al.
Publicado: (2016)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
por: Collignon, Catherine, et al.
Publicado: (2020)

Chimpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration
por: Wei-Zhang, Selena, et al.
Publicado: (2023)

Case Report of Serum Sickness-like Reaction following the First Dose of the Chimpanzee Adenovirus-Vectored AstraZeneca COVID-19 Vaccine, ChAdOx1
por: Alzaidi, Areej Awad, et al.
Publicado: (2023)

Nonclinical safety assessment of repeated administration and biodistribution of ChAd3‐EBO‐Z Ebola candidate vaccine
por: Planty, Camille, et al.
Publicado: (2020)

Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan
por: Younis, Brima M., et al.
Publicado: (2021)

Usefulness of the CHADS(2) and R(2)CHADS(2) scores for prognostic stratification in patients with coronary artery disease
por: Li, Yuerui, et al.
Publicado: (2018)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
por: Warimwe, George M, et al.
Publicado: (2013)

Omicron Subvariants, Including BA.4 and BA.5, Substantially Preserve T Cell Epitopes of Ancestral SARS-CoV-2
por: Park, Kyemyung, et al.
Publicado: (2022)

ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calves
por: de Jong, Rineke, et al.
Publicado: (2022)

Safety, mucosal and systemic immunopotency of an aerosolized adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques
por: Xu, Fang, et al.
Publicado: (2022)

Protective CD8(+) T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
por: Ewer, Katie J., et al.
Publicado: (2013)

Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag–pol–nef antigen
por: Herath, S., et al.
Publicado: (2015)

Non-clinical immunogenicity, biodistribution and toxicology evaluation of a chimpanzee adenovirus-based COVID-19 vaccine in rat and rhesus macaque
por: Dai, Xuedong, et al.
Publicado: (2022)

Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method
por: Roy, Chad J, et al.
Publicado: (2011)

Rift Valley Fever in Chad
por: Ringot, David, et al.
Publicado: (2004)

The Peculiar Epidemiology of Dracunculiasis in Chad
por: Eberhard, Mark L., et al.
Publicado: (2014)

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial
por: de Graaf, Hans, et al.
Publicado: (2021)

Usefulness of CHADS2, R2CHADS2, and CHA2DS2‐VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients
por: Wu, Yuzhong, et al.
Publicado: (2021)

Manufacturing a chimpanzee adenovirus‐vectored SARS‐CoV‐2 vaccine to meet global needs
por: Joe, Carina C. D., et al.
Publicado: (2021)

Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection
por: Liao, Po-Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iklnnh9v134ht7sishaihauaud